MENU
IOVA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Iovance Biotherapeutics (IOVA) Ownership - Who owns Iovance Biotherapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
825 Industrial Road
Phone
+1 650 260-7120
Employees
557
Web
https://www.iovance.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.74B
P/E Ratio
N/A
Total Cash
13.97M
Projected Growth
N/A
Total Debt
84.37M
Revenue
N/A
Risk (Beta)
1.17
Dividend Yield
N/A
Total Cash/Share
0.05
Total Debt/Equity
N/A
Revenue/Share
0.33 USD as % of share price
Fundamentals
IOVA
Capitalization
2.74B
P/E Ratio
N/A
Risk (Beta)
1.17
Dividend Yield
N/A
Total Cash
14M
Total Cash/Share
0.05
Total Debt
84.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.33%
Revenue
N/A
ROE
N/A
Book Value
680M
P/B Ratio
3.55
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
12K
Current Ratio
4.63
Current Revenue Per Employee
1283.66
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
-915.52
Revenue To Assets
N/A
Shares Held By Institutions
5.68B
Shares Outstanding - Current
305M
Total Liabilities
190M
Total Volume MTD
N/A
Value
N/A
Gain YTD
10.701
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of biotechnological products for the treatment of cancer
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
825 Industrial Road
Phone
+1 650 260-7120
Employees
557
Web
https://www.iovance.com